MDxHealth SA (MDXH)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $13.75M
Last updated: Nov 17, 2026 at 4:10 PM ET
MDxHealth SA (MDXH) Statistics
MDxHealth SA (MDXH) has a market cap of $13.75M and an enterprise value of $78.89M. Its share count is up 90.60% from a year earlier. Its net debt of $65.14M equals 473.74% of its market cap.
Total Valuation
Enterprise value is 473.74% above the market cap, as debt exceeds cash.
| Market Cap | $13.75M |
|---|---|
| Enterprise Value | $78.89M |
| Latest price (Nov 17, 2026) | $0.15 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 95.91% over 52 weeks and trades 63.41% below its 50-day average.
| Beta (1Y) | 2.04 |
|---|---|
| 52-Week Change | -95.91% |
| 1-Month Change | -18.67% |
| 3-Month Change | -80.37% |
| 6-Month Change | -82.25% |
| Total Return (1Y) | -95.91% |
| Total Return (3Y CAGR) | -63.51% |
| Total Return (5Y CAGR) | -57.23% |
| Max Drawdown (1Y) | -96.64% |
| Max Drawdown (3Y) | -97.21% |
| Sharpe Ratio (1Y) | -1.98 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $0.41 |
| 200-Day Average | $1.31 |
| 52-Week Range | $0.11 to $4.34 |
| RSI (14 Days) | 26.6 |
| Average Volume (20 Days) | 1.20M |
Financial Position
Current assets cover 1.28x current liabilities.
| Current Ratio | 1.28x |
|---|---|
| Quick Ratio | 1.10x |
| Interest Coverage | -1.19x |
Returns and Efficiency
Return on invested capital is -44.75% over the last 12 months, against a 5-year average of -58.08%.
| Return on Assets (ROA) | -23.96% |
|---|---|
| Return on Invested Capital (ROIC) | -44.75% |
| Return on Capital Employed (ROCE) | -33.94% |
| ROA (5Y Average) | -31.17% |
| ROIC (5Y Average) | -58.08% |
| Asset Turnover | 1.08x |
| Inventory Turnover | 10.10x |
| Receivables Turnover | 11.88x |
| Cash Conversion Cycle | 7 days |
Scores
MDXH has an Altman Z-Score of -3.88, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -3.88 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $159.25M over the last 12 months is up 26.00% from the 12 months before.
| Revenue | $159.25M |
|---|---|
| Revenue Growth (YoY) | +26.00% |
| Gross Profit | $90.54M |
| Operating Income | -$36.37M |
| Pretax Income | -$61.34M |
| Net Income | -$63.40M |
| EBITDA | -$19.55M |
| EBIT | -$33.47M |
| Reported EPS (TTM) | -$0.68 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $31.71M |
|---|---|
| Total Debt | $96.85M |
| Net Debt | $65.14M |
| Net Debt Per Share | $0.68 |
| Working Capital | $11.40M |
| Shareholder Equity | -$24.54M |
| Tangible Book Value | -$99.07M |
| Total Assets | $139.91M |
| Total Liabilities | $164.45M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $456.00K of capital spending, operating cash flow left -$8.77M of free cash flow.
| Operating Cash Flow | -$8.32M |
|---|---|
| Capital Expenditures | $456.00K |
| Free Cash Flow | -$8.77M |
| FCF Per Share | -$0.09 |
| Depreciation and Amortization | $13.93M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -22.84%, against a 5-year average of -60.73%.
| Gross Margin | 56.85% |
|---|---|
| Operating Margin | -22.84% |
| Pretax Margin | -38.52% |
| Net Margin | -39.81% |
| EBITDA Margin | -12.28% |
| EBIT Margin | -21.02% |
| FCF Margin | -5.51% |
| Gross Margin (5Y Average) | 56.58% |
| Operating Margin (5Y Average) | -60.73% |
| Net Margin (5Y Average) | -76.80% |
Growth
Revenue grew 42.79% a year over 3 years.
| Revenue Growth (3Y CAGR) | +42.79% |
|---|---|
| Revenue Growth (5Y CAGR) | +42.34% |
Dividends and Yields
MDXH does not pay a dividend. Its free cash flow yield is -61.71%.
| FCF Yield | -61.71% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 6 similar companies, MDXH has the 6th highest ROIC.
ROICPeer median -17.57%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.78%
| ROIC | -44.75% vs -17.57% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +26.00% vs +9.78% median |
Analyst Forecast
Consensus estimates put revenue growth at -2.15% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -2.15% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MDXH
What is MDXH's market cap?
MDxHealth SA has a market cap of $13.75M. Its enterprise value, which adds debt and subtracts cash, is $78.89M.
How many shares of MDXH are outstanding?
MDxHealth SA has 95.42M shares outstanding. The count is up 90.60% from a year earlier.
Does MDXH pay a dividend?
No. MDxHealth SA does not pay a dividend.
How much debt does MDXH have?
MDxHealth SA has $96.85M of total debt and $31.71M of cash and equivalents, a net debt position of $65.14M.
MDXH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors, Government Contracts